D Cold

# D Cold (Combination Product - Acetaminophen/Phenylephrine/Diphenhydramine) ## Overview - **Classification**: Analgesic, Antipyretic, Decongestant, First-Generation Antihistamine. - **Mechanism (Combination)**: **Acetaminophen** inhibits prostaglandin synthesis (analgesia, antipyresis). **Phenylephrine** is an alpha-1 agonist (vasoconstriction/decongestion). **Diphenhydramine** blocks H1 receptors (sedation/anticholinergic/relief of rhinorrhea). ## Primary Indications 1. **Symptomatic Relief of Cold/Flu**: Manages pain, fever, nasal congestion, and sneezing. 2. **Nighttime Cold Symptoms**: Diphenhydramine component aids sleep disrupted by symptoms. ## Adult Dosing *Note: D Cold typically contains Acetaminophen 500 mg, Phenylephrine 5-10 mg, and Diphenhydramine 25 mg per tablet.* ### Standard Dosing **Symptomatic Overnight Cold/Flu Relief** - **Dose**: **1 to 2 tablets** (Strength dependent) - **Frequency**: Every 4 to 6 hours as needed. - **Route**: Oral - **Maximum daily dose**: Do not exceed **4000 mg** Acetaminophen daily (from all sources). Do not take more than 6 doses in 24 hours. ### Dose Adjustments - **Renal Impairment**: Caution for acetaminophen toxicity. Extended dosing intervals may be needed if CrCl < 30 mL/min. - **Hepatic Impairment**: **CONTRAINDICATED** or requires significant dose reduction due to acetaminophen. Avoid or use minimum doses. - **Elderly Patients**: Start at the lower end of the dosing range. Increased sensitivity to anticholinergic effects (Diphenhydramine) and potential for falls. ## Pediatric Dosing **⚠️ WARNING**: Due to safety concerns, FDA and major pediatric bodies recommend against using combination cough and cold products (especially those containing decongestants/antihistamines) in children younger than 4 years old. ### Neonates (0-28 days) / Infants (1-12 months) - **Dose**: **CONTRAINDICATED.** - **Special Notes**: Do not use combination cold products in this age group due to risk of serious adverse events (cardiac, CNS toxicity). ### Children (1-12 years) - **Dose**: **CONTRAINDICATED.** (Unless single-ingredient acetaminophen is used) - **Special Notes**: Use single-ingredient products if needed (e.g., plain acetaminophen). Counsel parents rigorously. ### Adolescents (13-18 years) - **Dose**: Treat as adult dosing, typically **1 tablet** (Standard strength). - **Frequency**: Every 4 to 6 hours as needed. - **Maximum**: Follow adult **4000 mg/day** acetaminophen maximum limit. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to components (Acetaminophen, Phenylephrine, Diphenhydramine). - **Absolute**: Severe active liver disease or acute liver failure. - **Absolute**: Concurrent use of MAO Inhibitors or within 14 days of stopping MAOIs (Phenylephrine risk). - **Relative**: Severe uncontrolled hypertension or coronary artery disease. ### Common Adverse Effects - **Very Common (>10%)**: Drowsiness/Sedation (Diphenhydramine). - **Common (1-10%)**: Dizziness, dry mouth, blurred vision (Anticholinergic effects), nausea. - **Serious but Rare**: Hepatotoxicity (Acetaminophen overdose), severe skin reactions (SJS/TEN), paradoxical CNS excitation or seizures (children). ### Key Drug Interactions - **MAO Inhibitors (Isocarboxazid, Selegiline)**: Risk of **hypertensive crisis** and severe headache (Phenylephrine interaction). **CONTRAINDICATED.** - **CNS Depressants (Opioids, Benzodiazepines, Alcohol)**: Increased **sedation** and respiratory depression (Diphenhydramine additive effect). Avoid or use caution. - **Warfarin**: Chronic high-dose acetaminophen may increase INR; monitor closely. - **Anticholinergics (TCAs, Antispasmodics)**: Increased risk of urinary retention, constipation, and confusion (additive Diphenhydramine effects). ## Monitoring & Follow-up - **Before Treatment**: Assess baseline liver function in patients with known risk factors (alcohol abuse). Check blood pressure control. - **During Treatment**: Monitor for signs of severe sedation, dizziness, and hepatic toxicity (jaundice, fatigue). - **Clinical Signs**: Watch for fever/pain lasting >3 days or cold symptoms persisting >7 days, indicating need for further evaluation. ## Clinical Pearls - 💡 **Tip 1**: Advise patients this is a **sedating product**; avoid operating machinery or driving after taking. - 💡 **Tip 2**: Counsel patients to check all other products they are taking (Rx and OTC) for **acetaminophen (APAP)** content to prevent unintentional overdose. - 💡 **Tip 3**: Take with food or milk to minimize GI upset associated with Phenylephrine, though it may slow absorption slightly. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.